The Aminocaproic Acid Tablets, cataloged under National Stock Number 6505-01-696-3062, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Vitruvias Therapeutics, Inc. Dba Vitruvias Therapeutics. Government technical data includes 7 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-696-3062 |
| Primary Part Number | NDC69680-0115-30 |
| Item Name | Aminocaproic Acid Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Vitruvias Therapeutics, Inc. Dba Vitruvias Therapeutics |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Content Quantity | 30.0 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Protective Storage Feature | CONTROLLED ROOM TEMPERATURE |
| Active Medicament Medicinal Strength | 500.0 MILLIGRAMS AMINOCAPROIC ACID ACTIVE INGREDIENT |
| Total Primary Container Quantity | 30 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC69680-0115-30 PRIMARY | Vitruvias Therapeutics, Inc. Dba Vitruvias Therapeutics (USA) |
| NDC69238-1637-03 PRIMARY | Amneal Pharmaceuticals of New York, Llc (USA) |
| Reference | Meaning |
|---|---|
| 1598746 | 5/1 Secondary reference U.S. Government activity |
| 6505217225 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-696-3062 is a Aminocaproic Acid Tablets, manufactured by Vitruvias Therapeutics, Inc. Dba Vitruvias Therapeutics, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-696-3062 has 2 manufacturer part numbers on file: NDC69680-0115-30 (Vitruvias Therapeutics, Inc. Dba Vitruvias Therapeutics), NDC69238-1637-03 (Amneal Pharmaceuticals of New York, Llc).
Key specifications for NDC69680-0115-30: Administration: ORAL; Primary Container Content Quantity: 30.0 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE. 7 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.